Stay updated on S 055746 Dose Escalation in AML/MDS Clinical Trial
Sign up to get notified when there's something new on the S 055746 Dose Escalation in AML/MDS Clinical Trial page.

Latest updates to the S 055746 Dose Escalation in AML/MDS Clinical Trial page
- CheckyesterdayChange DetectedDifference1.0%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.9%
- Check15 days agoChange DetectedDifference1%
- Check23 days agoChange DetectedThe page has been updated to include new identifiers for a clinical study on Acute Myeloid Leukaemia (AML) and has revised the version number from v2.14.4 to v2.15.0. Additionally, the previous detailed study purpose and inclusion/exclusion criteria have been removed.SummaryDifference29%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.7%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.7%
Stay in the know with updates to S 055746 Dose Escalation in AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the S 055746 Dose Escalation in AML/MDS Clinical Trial page.